Search

Search Constraints

You searched for: Author/Creator Maishman, Tom

Search Results

2. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Issue 1 (December 2015)

3. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss. (December 2017)

4. Effectiveness of nurse‐led group CBT for hot flushes and night sweats in women with breast cancer: Results of the MENOS4 randomised controlled trial. Issue 10 (24th July 2020)

5. Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. Issue 5 (May 2019)

6. Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women. Issue 1 (December 2017)

9. Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First‐Line Therapy for Extensive‐Stage SCLC. Issue 9 (September 2016)

10. P013: MENOS4 trial: Nurses can be trained to effectively deliver CBT for menopausal hot flushes in women with breast cancer to reduce hot flush bother and improve quality of life. Issue 6 (June 2020)